Weiguo Ye sold $137k of GYRE
Chief Operating Officer at GYRE THERAPEUTICS, INC.. 22,220 shares at an average of $6.15, traded May 20, 2026, filed May 22, 2026.
Score components
- +20RoleCOO
- +11Trade size$137k at market
- 0Share of holdings soldSold 3.1% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-022642, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2026 | MOption exercise Common Stock | +9,400 | $0.75 | $7,050 | 709,400 | May 22, 2026 |
| May 20, 2026 | SOpen-market sale Common Stock | -9,400 | $6.15 | $58k | 700,000 | May 22, 2026 |
| May 21, 2026 | MOption exercise Common Stock | +12,820 | $0.75 | $9,615 | 712,820 | May 22, 2026 |
| May 21, 2026 | SOpen-market sale Common Stock | -12,820 | $6.15 | $79k | 700,000 | May 22, 2026 |
| May 20, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -9,400 | $0.00 | $0 | 917,715 | May 22, 2026 |
| May 21, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -12,820 | $0.00 | $0 | 904,895 | May 22, 2026 |
Related signals
Other insiders at GYRE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $69k 11,000 shares | -2% | |
| 5Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $17k 2,800 shares | -0% | |
| 16Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $129k 20,918 shares | -3% | |
| 17Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $219k 34,976 shares | -5% | |
| 11Weak | GYREsell GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $46k 7,500 shares | -1% | |
| 20Weak | GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $59k 9,320 shares | -1% | |
| 25Weak | GYRE THERAPEUTICS, INC. | Weiguo Ye Chief Operating Officer | $195k 28,680 shares | -4% | |
| 22Weak | GYRE THERAPEUTICS, INC. | Ying Luo Chief Executive Officer | $83k 10,315 shares | -0% | |
| 5Weak | GYRE THERAPEUTICS, INC. | Songjiang Ma President | $26k 2,558 shares | -0% | |
| 0Weak | GYRE THERAPEUTICS, INC. | Songjiang Ma President | $24k 2,182 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.